TickerFacts.

Creative Medical Technology Holdings, Inc. (CELZ): EPS (Diluted)

Annual figures by period end, from SEC filings.

-$2.52
Year ended 2025-12-31
$5.612020-12-31: -$62.692021-12-31: $5.612022-12-31: -$0.932023-12-31: -$3.762024-12-31: -$3.712025-12-31: -$2.52-$2.52
2020-12-31 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31-$2.52n/m2026-03-20, From 2025-01-01
2024-12-31-$3.71n/m2026-03-20, From 2024-01-01
2023-12-31-$3.76n/m2025-03-14, From 2023-01-01
2022-12-31-$0.93n/m2023-03-31, From 2022-01-01
2021-12-31$5.61n/m2023-03-31, From 2021-01-01
2020-12-31-$62.69n/a2022-03-30, From 2020-01-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Creative Medical Technology Holdings, Inc. (CELZ)2025-12-31-$2.52n/m
Senti Biosciences Holdings, Inc. (SNTI)2025-12-31-$2.73n/m
Entera Bio Ltd. (ENTX)2025-12-31$0.250.0%
Inmune Bio, Inc. (INMB)2025-12-31-$1.86n/m
AIM ImmunoTech Inc. (AIM)2025-12-31-$8.62n/m
VivoSim Labs, Inc. (VIVS)2026-03-31-$5.35n/m
Zivo Bioscience, Inc. (ZIVO)2024-12-31-$4.23n/m
aTYR PHARMA INC (ATYR)2025-12-31-$0.80n/m
Cardiff Oncology, Inc. (CRDF)2025-12-31-$0.69n/m

Compare CELZ, SNTI, ENTX, INMB side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗